Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Salivary Gland Cancer

Salivary gland cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Published online: 02 November 2022
van Herpen C, Vander Poorten V, Skalova A, et al, on behalf of the ESMO Guidelines Committee

  • This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer.
  • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
  • Treatment algorithms for parotid, submandibular, sublingual and minor salivary gland cancer are provided.
  • The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe.
  • Recommendations are based on available scientific data and the authors’ collective expert opinion.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.